Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by houbahopon Oct 30, 2023 7:35pm
94 Views
Post# 35708327

RE:Contradictory

RE:Contradictory "Inconsistent, contradictory, conflicting, confusing...= not believable, not trustable, not respectable..."

It's about time you wake up, scarlet1967.

Welcome to Thera's shareholders reality: Thera's Board of Directors don't give a fly.ng fock about their fiduciary duties towards their shareholders. This was exposed some years ago, and like most chearleaders on this forum, it was your decision to turn a blind eye to this so very important criteria in investment. Paul and his cronies on the Board should never have survived the last shareholders meeting neither the previous one. By not sending a strong message, shareholders have left the door wide open for what has happened. Today, these same shareholders have to take responsibility for the course of events. Tough to swallow, huh?

And now, like some are presently saying, it's to late to get out.
Do you feel the pain and see the eventual death by a thousand cut?

This is what Thera's BOD and upper management always had on the menu for their shareholders.

"As for bringing in new shareholders for job security if true how long does it take for our new friends to realize this board/leadership can't be trusted? "

Good one... how many years did it take you to realize this board/leadership can't be trusted?


But today, they have enough money to last a couple of years. I wonder what will be their next move to destroy shareholders' value... Before then, hopefully the stock price can climb up to $4 so I can dump the few thousands shares I have.

Sad...
<< Previous
Bullboard Posts
Next >>